Their results highlight the novel connection between SRSF11-regulated splicing and CRC metastasis via HSPA12A, indicating that the PAK5/SRSF11/HSPA12A axis could serve as a promising therapeutic target and prognostic biomarker for CRC (177). This evidence concerns the gene SRSF11 and colorectal carcinoma.